MedPAC > Our Work > Drugs, Devices, and Tests > Initial findings from MedPAC’s analysis of Part D data on drug rebates and discounts Initial findings from MedPAC’s analysis of Part D data on drug rebates and discounts Apr 07, 2022 / Presentations Download Full Presentation